Also known as Recipharm Group AG.
None yet. When a new project in the record names Recipharm AG as owner, partner or investor, it shows here.
Board chair Thomas Leysen will retire; shareholders will vote on Richard Ridinger at an Extraordinary General Meeting on 19 Oct 2026.
